Recent development of gold (I) and gold (III) complexes as therapeutic agents for cancer diseases
Y Lu, X Ma, X Chang, Z Liang, L Lv, M Shan… - Chemical Society …, 2022 - pubs.rsc.org
Metal complexes have demonstrated significant antitumor activities and platinum complexes
are well established in the clinical application of cancer chemotherapy. However, the …
are well established in the clinical application of cancer chemotherapy. However, the …
[HTML][HTML] Metallodrugs are unique: Opportunities and challenges of discovery and development
EJ Anthony, EM Bolitho, HE Bridgewater… - Chemical …, 2020 - pubs.rsc.org
Metals play vital roles in nutrients and medicines and provide chemical functionalities that
are not accessible to purely organic compounds. At least 10 metals are essential for human …
are not accessible to purely organic compounds. At least 10 metals are essential for human …
Metallodrugs in cancer nanomedicine
Metal complexes are extensively used for cancer therapy. The multiple variables available
for tuning (metal, ligand, and metal–ligand interaction) offer unique opportunities for drug …
for tuning (metal, ligand, and metal–ligand interaction) offer unique opportunities for drug …
Cisplatin: The first metal based anticancer drug
S Ghosh - Bioorganic chemistry, 2019 - Elsevier
Abstract Cisplatin or (SP-4-2)-diamminedichloridoplatinum (II) is one of the most potential
and widely used drugs for the treatment of various solid cancers such as testicular, ovarian …
and widely used drugs for the treatment of various solid cancers such as testicular, ovarian …
Copper in tumors and the use of copper-based compounds in cancer treatment
DA da Silva, A De Luca, R Squitti, M Rongioletti… - Journal of inorganic …, 2022 - Elsevier
Copper homeostasis is strictly regulated by protein transporters and chaperones, to allow its
correct distribution and avoid uncontrolled redox reactions. Several studies address copper …
correct distribution and avoid uncontrolled redox reactions. Several studies address copper …
Therapeutic strategies to overcome cisplatin resistance in ovarian cancer
M Song, M Cui, K Liu - European journal of medicinal chemistry, 2022 - Elsevier
Ovarian cancer (OC) is one of the most common gynecologic tumors worldwide and one
with the highest mortality. Cisplatin (DDP) is the first platinum-based complex approved by …
with the highest mortality. Cisplatin (DDP) is the first platinum-based complex approved by …
[HTML][HTML] A comprehensive review on the synthesis, characterization, and biomedical application of platinum nanoparticles
Platinum nanoparticles (PtNPs) are noteworthy scientific tools that are being explored in
various biotechnological, nanomedicinal, and pharmacological fields. They are unique …
various biotechnological, nanomedicinal, and pharmacological fields. They are unique …
[HTML][HTML] The drug-resistance mechanisms of five platinum-based antitumor agents
J Zhou, Y Kang, L Chen, H Wang, J Liu… - Frontiers in …, 2020 - frontiersin.org
Platinum-based anticancer drugs, including cisplatin, carboplatin, oxaliplatin, nedaplatin,
and lobaplatin, are heavily applied in chemotherapy regimens. However, the intrinsic or …
and lobaplatin, are heavily applied in chemotherapy regimens. However, the intrinsic or …
[HTML][HTML] Metallo-drugs in cancer therapy: Past, present and future
Cancer treatments which include conventional chemotherapy have not proven very
successful in curing human malignancies. The failures of these treatment modalities include …
successful in curing human malignancies. The failures of these treatment modalities include …
[HTML][HTML] Colorectal carcinoma: a general overview and future perspectives in colorectal cancer
I Mármol, C Sánchez-de-Diego… - International journal of …, 2017 - mdpi.com
Colorectal cancer (CRC) is the third most common cancer and the fourth most common
cause of cancer-related death. Most cases of CRC are detected in Western countries, with its …
cause of cancer-related death. Most cases of CRC are detected in Western countries, with its …